Page last updated: 2024-09-03

gamma-carboline and etoposide

gamma-carboline has been researched along with etoposide in 2 studies

Compound Research Comparison

Studies
(gamma-carboline)
Trials
(gamma-carboline)
Recent Studies (post-2010)
(gamma-carboline)
Studies
(etoposide)
Trials
(etoposide)
Recent Studies (post-2010) (etoposide)
4402618,3063,6934,900

Protein Interaction Comparison

ProteinTaxonomygamma-carboline (IC50)etoposide (IC50)
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]Homo sapiens (human)1.153
nuclear receptor coactivator 3 isoform aHomo sapiens (human)1.4284
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)3.187
Caspase-3Homo sapiens (human)1
DNA topoisomerase 2-betaHomo sapiens (human)0.4299
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)4.18

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bisagni, E; Fossé, P; Nguyen, CH; Paoletti, C; René, B; Saucier, JM1
Amaladass, P; Chidara, S; Damerla, VSB; Gupta, S; Karmakar, A; Mogili, P; Pasunooti, KK; Puli, VS; Voggu, R1

Other Studies

2 other study(ies) available for gamma-carboline and etoposide

ArticleYear
Stimulation by gamma-carboline derivatives (simplified analogues of antitumor ellipticines) of site specific DNA cleavage by calf DNA topoisomerase II.
    Biochemical pharmacology, 1990, Feb-15, Volume: 39, Issue:4

    Topics: Amsacrine; Animals; Antineoplastic Agents; Base Sequence; Carbolines; Cattle; Deoxyribonucleases, Type II Site-Specific; DNA Restriction Enzymes; DNA Topoisomerases, Type II; DNA, Bacterial; Ellipticines; Etoposide; Molecular Sequence Data; Molecular Structure; Plasmids; Structure-Activity Relationship

1990
Design, Synthesis, Molecular Docking Study and Biological Evaluation of Novel γ-Carboline Derivatives of Latrepirdine (Dimebon) as Potent Anticancer Agents.
    Molecules (Basel, Switzerland), 2023, Jun-24, Volume: 28, Issue:13

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship

2023